ABSTRACT
In general, men have poorer health status compared to women 1 : with higher all-cause and disease-specific mortality rates and shorter life expectancy and healthy life expectancy. 2, 3 In 2015, the life expectancy at birth for Canadians was 79.5 years for males and 83.9 years for females. 2 Canadian men also have higher disability-adjusted life years (DALYs), an expression of total health loss due to disability and premature mortality. The fact that men have shorter lifespans is often left unquestioned in practice and presumed to be 'natural' or inevitable. 1 However, the top risk factors that waste the healthy life years of Canadian men and women 4 can be reduced by upstream healthy lifestyle improvements.
Gender is a key determinant of health, and gender inequity is a key contributor to health inequalities. 5 While previous health-related gender discussion has been focused on women's health issues, men's health promotion would also benefit from a similar genderbased male-focused lens. 6 The concept of "men's health" encompasses all health issues that shorten life expectancy or reduce quality of life: lifestyle factors, health behaviours, and the way in which men perceive and react to their health risks. In Canada, the concept of men's health is capturing the interest of various stakeholders, in much the same way as earlier initiatives that improved the health and lives of girls and women. 5 Risk prediction models consider multiple risk factors to estimate the probability that a certain outcome is present or will occur in an individual. 7 Although individualized health risk assessment tools already exist for specifi c diseases and conditions in clinical and public health use domains, [8] [9] [10] there are none that assess multiple disease risks simultaneously with the same sets of questions, and provide health promotion messages that are comprehensible to the general public. The Canadian Men's Health Foundation (CMHF) has developed and validated a self-risk assessment tool called "You Check" (youcheck.ca), designed to provide simultaneous risk assessment for multiple diseases using a holistic approach to health promotion and communication, with real-life health promotion follow-up strategies. This paper presents the development methodology and the results of internal validation of this risk assessment tool.
METHODS

Development of the Risk Tool
To select the diseases for inclusion in our tool, we reviewed the results of the global burden of disease 2010 study for Canada 11 and selected the most burdensome and largely preventable diseases as well as conventional men's health conditions. We looked at the 10-year risk of developing myocardial infarction (MI), type 2 diabetes, prostate cancer, osteoporosis, erectile dysfunction (ED), low testosterone (LT), and the current risk of major depression. Clinical experts from Vancouver General Hospital and the University of British Columbia's Faculty of Medicine selected the key predictors that could be readily measured in an online questionnaire. The selected risk factors included age, ethnicity, family history, diet, smoking history, body mass index (BMI), blood pressure, alcohol intake, plasma glucose, total cholesterol, level of physical activity, sleep duration, and presence of snoring. We found limited evidence for risk factors in predicting the onset of depression in our literature review. Our expert panel also determined that the underdiagnosis of depression in men and delay in treatment leading to the risk of suicide was of greater public health importance. As such, we identified the 10-item version of Center for Epidemiologic Studies' Depression (CES-D) questionnaire 12,13 as the shortest possible and validated questionnaire for current risk of depression for inclusion in our tool. Hence, depression was not included in our You Check risk model development and validation. © 2017 The Dougmar Publishing Group All rights reserved.
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To develop risk scores, clinical experts assigned weighting to each risk factor and disease pair based on their experience and knowledge of available literature. Forty hypothetical patients were then created, with and without each of the target diseases, and a "risk score" and an "importance score" were then assigned for each risk factor in each of the target diseases in each of these cases. The weightings were "fi ne-tuned" to maximize the ability to predict for the known outcome. Risk scores used a 5-point Likert scale to indicate the likelihood of a given risk factor being related to a given disease. The importance score weighted each risk factor, ranging from −3 to 30, where 30 indicated the most signifi cant predisposing risk and negative values indicated protective eff ects. For each risk factordisease pairing, the product of the risk score and the importance score was the "risk value" which was then used to calculate a risk percent using the formula: risk percent = (calculated risk value -minimum risk value) / (maximum risk value -minimum risk value). Finally, the risk percentages for each disease were categorized as low, intermediate, or high risk, using 2 cut off points for each disease:
Low-risk, if 0 ≤ RP < LCOP; Medium-risk, if LCOP ≤ RP < UCOP; High risk, if UCOP ≤ RP ≤ 100 (where RP = Risk Percent, LCOP = Lower Cut Off Point, and UCOP = Upper Cut Off Point).
Internal Validation of the Risk Tool
For internal validation of the risk models, we used a case-control study design. Four family practice medical clinics in Vancouver (Spectrum Health Care and The Doctors Office) and Burnaby (Central Park Medical Clinic and Old Orchard Medical Clinic) were reviewed from October 2013 to January 2014. Cases were men with a known diagnosis (based on ICD-9 codes) of at least one of the target diseases between 2010 and 2013 with a minimum of 8-10 years of medical records before the year of diagnosis. Records had to contain documentation of at least 3 out of 5 biological risk factors (BMI, waist circumference, blood pressure, fasting blood glucose, and total serum cholesterol) and at least 2 out of 5 lifestyle risk factors (smoking, alcohol consumption, physical activity, eating habits, and sleeping at least 7 hours in a 24-hour period). Controls were age-matched male patients from the same family practice clinics who did not have the target disease or a diagnosis closely related to the target disease. Sample size was determined using the rule of a minimum of 10 observations per variable. 14 The minimum diagnostic criteria for each of the 5 diseases are shown in Table 1 .
Cases and controls were reviewed by a single, unblinded researcher through retrospective, anonymized chart review. The reviewer applied the "You Check" questionnaire to the latest encounter date in the medical record. Since the tool only allows a non-response ("I prefer not to respond" or "I don't know") for ethnic background, waist circumference, blood pressure, blood glucose, blood cholesterol, family history of diseases, and a query on firmness e12 of erections when needed, then in cases where there were no data available in the chart, risk scores and importance scores were assigned based on average population values. For weight, fasting blood glucose, total blood cholesterol, and blood pressure, the average levels over the 10-year time interval before diagnosis of the target disease were used.
Data from 110 records without the 7 conditions were collected to create the control group. For this group, age at diagnosis was defined as age at last encounter. To adjust for the confounding effect of age on disease risk, cases and controls were matched on age. For each disease, one nearest age-match control was chosen without replacement. Stata software version 13.1 was used for statistical analysis (StataCorp, College Station, Texas). Propensity score matching command was used in Stata (psmatch2 module, version 4.0.10, dated 10 Feb 2014, by E. Leuven and B. Sianesi). Descriptive and bivariate inferential analyses were performed for each "risk factor-disease" pair. Pearson chi-square and point and interval estimate of odds ratio were used for binary and non-ordinal categorical risk factors. Chi-square for linear trend was used for ordinal categorical risk factors. Student's t-test was used for continuous risk factors. A significance level of 0.05 was chosen for inferential analyses.
Area Under Curve (AUC) of the Receiver Operating Characteristic (ROC) curve was used as the discrimination measure, and sensitivity and specificity were used as classification measures. 15, 16 To control for over-optimism in estimation of internal validity we used bootstrap resampling. 17 For each disease, bootstrap resampling stratified by cases and controls was used with 1,000 draws. We set our goal for risk model accuracy as being at least at moderate level of statistical accuracy, such as AUC values ≥ 0.7.
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ROC analysis was used for determination of 2 optimal thresholds to be used for categorization of risk of disease in 10 years as low, medium, or high.
The first threshold was defined by breaking the spectrum of risk percentages into high-and low-risk categories, using the cutoff point which gave the highest correct classification. The high-risk category was then further split in 2, in order to create the medium and high-risk categories, using the same approach. For diseases with 2 tied (repetitive) values of maximum correct classifi cation proportion (yielding diff erent correspondent values of sensitivity and specifi city for each tie), the cutoff point with higher specifi city was chosen, and in the case of 3 ties, the cutoff point with the median value of specifi city was used. Specifi city was used to prevent false-positive alarms being given to users who are not at the highest or higher actual risk of disease.
For diseases with AUC < 0.7, the original risk scores and importance scores were adjusted empirically to increase their discriminative accuracy in a subsequent ROC curve analysis. The empirical adjustment of risk scores and importance scores was guided by considering the tabulation and graphic visualization of joint distribution of the risk factors and the disease among cases and controls. In case the AUC for an adjusted model did not reach the minimum target set for AUC, we used a risk-factor profi le approach. That was the case for prostate cancer, for which we had intentionally not included Prostatic-Specifi c Antigen (PSA) as a risk factor. We used a risk-factor profi le approach based on clinical and patient guidelines.
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The optimal cutoff point for the 10-item depression scale of the Center for Epidemiologic Studies (CES-D) was identifi ed as being equal to or greater than 10, categorizing its risk continuum of 0 to 30 into 2 categories of low or high risk of current depression. 12 In developing the results and recommendations section of the online tool, we used the approach of small sequential changes for improvement of healthy life style factors, based on the Transtheoretical Model (TTM) for behaviour change.
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RESULTS
The "You Check" tool assesses the risk of MI and diabetes and current risk of major depression as selected from the top 10 causes of DALYs in Canadian men in 2010. 11 Osteoporosis was included because it is commonly underrecognized as a disease of aging men, as it is generally considered by both the public and health professionals as a women's health condition. 23 Prostate cancer, ED, and LT were selected as common and publicly recognized men's health conditions. DALYs for the 7 diseases selected for inclusion in our risk tool are summarized in Table 2 .
Model Validation. For each target disease, we identifi ed 50 cases and 50 controls with adequate data, except for MI, which had 40 cases and 40 controls. The distributions of risk values and risk percentages by cases and controls for each disease are summarized in Tables 3 and 4 , respectively. ROC curves for diabetes type 2 and for all diseases are shown in Figures 1 and  2 , respectively. The fi rst models using the identifi ed cutoff points for prostate cancer and ED had AUC < 0.7. Model refi nement and retest improved AUC for ED to 0.66 (95% Confi dence Interval 0.58 to 0.74) but AUC for prostate cancer remained as low as 0.52 (95% CI 0.41 to 0.62). Therefore, the original risk 
DISCUSSION
"You Check" is unique in that it provides men a user-friendly questionnaire that addresses 7 target diseases at one time. Before releasing this self-risk assessment tool into the public domain, we sought to validate it internally using male patient data from primary care physician practices. We were able to demonstrate moderate internal validity of the "You Check" risk model (AUC ≥ 0.70) for type 2 diabetes, MI, LT, and osteoporosis; and modest internal validity for ED. For prostate cancer, we chose a "risk-factor profi le" approach, designating respondents' risk profi les as high, intermediate, or low, rather than categorizing them according to actual development of the disease.
In developing the "You Check" tool we did not use the conventional method of choosing coeffi cients from multivariable models for derivation of the risk scores in our risk models, but used clinician-assigned scores. Although this is not the optimal method for development of risk scores, important risk models have been developed using clinician-assigned scores such as the Apgar score, 24 Glasgow Coma Scale, 25 Norton, Waterlow, and Braden scores for pressure ulcers, 26 and American Society of Anesthesiologists (ASA) physical status score for prediction of perioperative and anesthetic-related mortality. 27 Altman and Royston 14 and Zhou et al. 28 discuss the signifi cance of expert based risk prediction models -such as You Check -for meeting clinical and public health objectives, when high-level, statistically generated accurate risk models (i.e. AUC ≥ 0.90) are not feasible or available.
There are multiple validated prediction tools for a variety of diff erent diseases. In general, the sensitivity and specifi city of risk prediction models can be 29 In this study, the sensitivity and specifi city of the "You Check" diabetes model are 0.86 and 0.84, respectively, for the lower cutoff and 0.54 and 0.96 for the higher cutoff . In comparison, the sensitivity and specifi city of the Finnish diabetes risk assessment tool (FINDRISK) are 0.78 and 0.76 respectively, in their 1987 cohort for a point score ≥ 9, both of which are high. 30 The Australian diabetes risk model (AUSDRISK) has a high sensitivity of 0.74 and a moderate specifi city of 0.68, for a point score ≥12. 31 For the Canadian diabetes risk assessment tool (CANRISK), these values are respectively 0.95 and 0.28 (for "Slightly elevated" risk category, i.e. score 21 in paper version of CANRISK), 0.70 and 0.67 (for "Balanced" risk category, i.e. score 32 in paper version of CANRISK), and 0.30 and 0.94 (for "Very high" risk category, i.e., score 43 in paper version of CANRISK). 10 For cardiovascular risk, the Framingham global model has a sensitivity of 0.46 and specifi city of 0.83. 8 These values are 0.46 and 0.83 respectively for the Scottish cardiovascular risk model (ASSIGN) 32 The Systematic Coronary Risk Evaluation model (SCORE) has combinations of moderate or low sensitivity (from 0.19 to 0.97) and specifi city (from 0.15 to 0.95) based on diff erent sets of validation cohorts and cut off levels. 33 In our "You Check" model, the sensitivity and specifi city of MI are 0.70 and 0.75 respectively for the lower cutoff and 0.40 and 0.93 for the higher cutoff .
Discriminative ability measures (AUC or c statistic) of risk prediction models can be categorized as excellent (0.90-1.00), good (0.80-0.89), modest or 35 For cardiovascular risk Harrell's c statistic is 0.71 for the Reynolds global score for men. 36 The AUC value for Scottish cardiovascular risk model (ASSIGN) is 0.73 for men. 32 The "You Check" risk model for MI has an AUC of 0.75.
This study has several limitations. First, random and systematic errors in self-reported health data, and misclassifi cation in disease ascertainment could aff ect the model's accuracy. Secondly, non-probability sampling tends to reduce the internal and external generalizability of the results, especially if the sampling list includes known and unknown specifi c patterns. As we used the reverse chronological list of the patient encounters that spanned over several months, the likelihood of the presence of known and unknown specifi c patterns in patient encounters were minimized. Thirdly, when a reviewer is not blinded to the case or control status of the patients, diff erential measurement bias might occur unintentionally or intentionally. However, if the reviewer takes note of potential sources of bias and diligently uses the same degree of meticulousness in standard chart review procedures regardless of the case or control status, these sources of bias are minimized. Another limitation was missing data on ethnicity, physical activity, and healthy eating habits which were generally lacking in the clinical charts.
CONCLUSIONS
Overall, the results of this study demonstrate that the risk models developed for the CMHF online risk assessment tool are internally valid. External validation of the tool is in progress. We are currently evaluating the actual eff ects on health behaviour and disease outcomes of men who use "You Check".
